122 related articles for article (PubMed ID: 2560775)
1. Prognostic significance of myeloperoxidase positivity of blast cells in acute myeloblastic leukemia without maturation (FAB: M1): an ECOG study.
Matsuo T; Cox C; Bennett JM
Hematol Pathol; 1989; 3(4):153-8. PubMed ID: 2560775
[TBL] [Abstract][Full Text] [Related]
2. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
Klobusicka M; Kusenda J; Babusikova O
Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of myeloperoxidase expression in childhood acute myeloid leukemia.
Roberson JR; Onciu M; Pounds S; Rubnitz JE; Pui CH; Razzouk BI
Pediatr Blood Cancer; 2008 Mar; 50(3):542-8. PubMed ID: 17763467
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells.
Lanza F; Latorraca A; Moretti S; Castagnari B; Ferrari L; Castoldi G
Cytometry; 1997 Jun; 30(3):134-44. PubMed ID: 9222099
[TBL] [Abstract][Full Text] [Related]
5. The percentage of myeloperoxidase-positive blast cells is a strong independent prognostic factor in acute myeloid leukemia, even in the patients with normal karyotype.
Matsuo T; Kuriyama K; Miyazaki Y; Yoshida S; Tomonaga M; Emi N; Kobayashi T; Miyawaki S; Matsushima T; Shinagawa K; Honda S; Ohno R;
Leukemia; 2003 Aug; 17(8):1538-43. PubMed ID: 12886240
[TBL] [Abstract][Full Text] [Related]
6. Role of immunophenotyping in characterisation of blast crisis of chronic myeloid leukemia--a study of 25 cases.
Padmanabhan V; Varma N; Dash S; Varma S
Indian J Pathol Microbiol; 1996 Jan; 39(1):13-7. PubMed ID: 8755126
[TBL] [Abstract][Full Text] [Related]
7. [Cytochemical evaluation of blast cells in acute myeloblastic leukemia after induction of their maturation in liquid culture--diagnostic usefulness].
Hansz J; Sawiński K; Woźny T
Pol Arch Med Wewn; 1992 Jul; 88(1):1-10. PubMed ID: 1333591
[TBL] [Abstract][Full Text] [Related]
8. Nonspecific esterase of acute promyelocytic leukemia (M3).
Matsuo T; Jain NC; Bennett JM
Am J Hematol; 1988 Nov; 29(3):148-51. PubMed ID: 3189310
[TBL] [Abstract][Full Text] [Related]
9. Myeloperoxidase cytochemical negativity: an unexpected but intrinsic property of blasts of all phases of chronic myeloid leukemia.
Anand M; Ghara N; Kumar R; Singh S; Sengar M; Panikar N; Raina V; Sharma A
Ann Hematol; 2005 Nov; 84(12):767-70. PubMed ID: 15990995
[TBL] [Abstract][Full Text] [Related]
10. Use of myeloperoxidase mRNA as a marker for myeloid lineage in acute leukemias.
Crisan D; David D; DiCarlo R
Arch Pathol Lab Med; 1996 Sep; 120(9):828-34. PubMed ID: 9140287
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
[TBL] [Abstract][Full Text] [Related]
12. [Cytochemical findings in acute promyelocytic leukemias].
Lemez P
Sb Lek; 1988 Jan; 90(1):14-20. PubMed ID: 2835811
[No Abstract] [Full Text] [Related]
13. Measurement of myeloid maturation by flow cytochemistry in HL-60 leukemia: esterase is inducible, myeloperoxidase is not.
Ross DW
Cytometry; 1986 May; 7(3):263-7. PubMed ID: 3011371
[TBL] [Abstract][Full Text] [Related]
14. Cytochemical and electrophoretic characterisation of alpha naphthyl acetate esterases (ANAE) in acute myeloblastic leukaemia.
Scott CS; Limbert HJ; Bynoe AG; Roberts BE
Blut; 1984 Oct; 49(4):331-8. PubMed ID: 6593104
[TBL] [Abstract][Full Text] [Related]
15. Definition of acute biphenotypic leukemia.
Matutes E; Morilla R; Farahat N; Carbonell F; Swansbury J; Dyer M; Catovsky D
Haematologica; 1997; 82(1):64-6. PubMed ID: 9107085
[TBL] [Abstract][Full Text] [Related]
16. [Ultrastructure of blast cells in patients with myeloblastic, monoblastic and myelomonoblastic leukemia].
Golovin AV; Vorob'ev IA; Tikhonova LIu; Chentsov IuS
Ter Arkh; 1985; 57(5):101-4. PubMed ID: 3860997
[TBL] [Abstract][Full Text] [Related]
17. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
[TBL] [Abstract][Full Text] [Related]
18. Myeloperoxidase-deficient polymorphonuclear leucocytes. (II) Longitudinal study in acute myeloid leukaemia, untreated, in remission and in relapse.
Bendix-Hansen K; Nielsen HK
Scand J Haematol; 1983 Jul; 31(1):5-8. PubMed ID: 6306759
[TBL] [Abstract][Full Text] [Related]
19. The ultrastructure of hybrid acute leukemia: a study of 15 cases.
Ru YX; Wang HJ; Yang BX; Liu JH; Li ZQ; Li CW; Wang JX; Mi YC
Ultrastruct Pathol; 2005; 29(5):341-7. PubMed ID: 16257860
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic value of early treatment response in children with acute myeloid leukemia].
Tie LJ; Gu LJ; Song DL; Xue HL; Tang JY; Dong L; Pan C; Chen J; Ye H; Chen J; Wang YP; Zou JY
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1837-40. PubMed ID: 17054861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
